Corcept Therapeutics Incorporated
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY1999 | — | $-244.0K | — |
| FY2000 | — | $-2.0M | — |
| FY2001 | — | $-7.5M | — |
| FY2002 | — | $-21.9M | — |
| FY2003 | — | $-31.5M | — |
| FY2004 | — | $45.9M | — |
| FY2005 | — | $26.6M | — |
| FY2006 | — | $6.4M | — |
| FY2007 | — | $14.7M | — |
| FY2008 | — | $16.9M | $14.7M |
| FY2009 | — | $22.1M | $23.9M |
| FY2010 | — | $21.2M | $24.6M |
| FY2011 | — | $34.8M | $39.6M |
| FY2012 | $29.0M | $61.8M | $93.0M |
| FY2013 | $29.3M | $21.0M | $54.9M |
| FY2014 | $24.5M | $-3.4M | $24.2M |
| FY2015 | $12.5M | $18.5M | $40.4M |
| FY2016 | $0 | $41.4M | $51.5M |
| FY2017 | $0 | $191.0M | $31.1M |
| FY2018 | — | $275.9M | $41.6M |
| FY2019 | — | $371.2M | $31.3M |
| FY2020 | — | $523.3M | $76.2M |
| FY2021 | — | $375.8M | $77.6M |
| FY2022 | — | $501.8M | $66.3M |
| FY2023 | — | $506.7M | $135.6M |
| FY2024 | — | $679.6M | $127.7M |
| FY2025 | — | $647.8M | $120.5M |